THE USE OF DEXMEDETOMIDINE IN REDUCING THE SYMPTOMS OF DELIRIUM AND PSYCHOMOTOR AGITATION POST-ANESTHESIA

Authors

  • Wallace Cauã Barbosa Da Silva Franco Unifip
  • Everson Vagner de Lucena Santos Unifip

DOI:

https://doi.org/10.66104/vrr9wh31

Keywords:

Therapeutics; Anesthesia; Psychomotor Agitation.

Abstract

Introduction: Postoperative delirium and psychomotor agitation are frequent complications after anesthesia, associated with worse clinical outcomes. Dexmedetomidine has been proposed as a pharmacological strategy for the prevention and control of these events. Objective: To evaluate whether the use of dexmedetomidine reduces the incidence of delirium and psychomotor agitation in patients during the perioperative period. Methods: This is a systematic review of interventions, conducted according to PRISMA recommendations. The search was carried out in the PubMed, Cochrane Library, BVS, ScienceDirect, and LIVIVO databases in January 2026. Randomized clinical trials and cohort studies published in the last 20 years were included. The risk of bias was assessed using the RoB 2 tool and the Newcastle-Ottawa Scale. Results: Seven studies were included in the final synthesis. It was observed that dexmedetomidine was associated with a reduction in psychomotor agitation and delirium, especially in pediatric populations and in an intensive care environment. The most frequent adverse effects were bradycardia and hypotension, generally mild. Conclusion: Dexmedetomidine shows potential benefit in reducing delirium and psychomotor agitation in the perioperative period. However, the heterogeneity of the studies indicates the need for additional clinical trials to confirm these findings.

Downloads

Download data is not yet available.

References

ABDEL-RAHMAN, K. A.; ABD-ELSHAFY, S. K.; SAYED, J. A. Effect of two different doses of dexmedetomidine on the incidence of emergence agitation after strabismus surgery: a randomized clinical trial. Brazilian Journal of Anesthesiology, v. 68, n. 6, p. 571–576, 2018. DOI: https://doi.org/10.1016/j.bjan.2018.05.002. DOI: https://doi.org/10.1016/j.bjane.2018.05.001

CARVALHO, L. A. Fisiopatologia do delirium no perioperatório: além dos neurotransmissores. Revista de Medicina, São Paulo, v. 102, n. 2, p. 1–10, 2023. DOI: https://doi.org/10.11606/issn.1679-9836.v102i2p1-10.

CHEN, X. et al. Comparison of remimazolam and dexmedetomidine on postoperative delirium and emergence agitation in elderly patients undergoing thoracoscopic surgery: a randomized, double-blind, non-inferiority trial. Drug Design, Development and Therapy, v. 19, p. 9671–9681, 2025. DOI: https://doi.org/10.2147/DDDT.S548418. DOI: https://doi.org/10.2147/DDDT.S548418

DUTTA, S. et al. Dexmedetomidine in perioperative care: current evidence and future perspectives. Journal of Clinical Anesthesia, v. 88, p. 111097, 2024. DOI: https://doi.org/10.1016/j.jclinane.2023.111097.

GOVÊIA, C. S. et al. Dexmedetomidine reduces postoperative cognitive and behavioral dysfunction in adults submitted to general anesthesia for non-cardiac surgery: meta-analysis of randomized clinical trials. Brazilian Journal of Anesthesiology, v. 71, n. 4, p. 413–420, 2021. DOI: https://doi.org/10.1016/j.bjane.2021.02.020. DOI: https://doi.org/10.1016/j.bjane.2021.02.020

GUO, Y. et al. [Título não especificado]. Shanghai Journal of Stomatology, v. 24, n. 2, p. 236–239, 2015.

HIGGINS, J. P. T. et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ, v. 343, p. d5928, 2011. DOI: https://doi.org/10.1136/bmj.d5928 DOI: https://doi.org/10.1136/bmj.d5928

HONÓRIO, H. M; SANTIAGO JUNIOR, J. F.; PERALYA-MAMANI, M. Análise qualitativa da revisão sistemática. In: HONÓRIO, H. M; SANTIAGO JUNIOR, J. F. Fundamentos das revisões sistemáticas. São Paulo: Editora Quintessence, p. 205-231, 2021.

HU, Y. et al. The neuroprotective effect of dexmedetomidine and its mechanism. Frontiers in Pharmacology, v. 13, p. 965661, 2022. DOI: https://doi.org/10.3389/fphar.2022.965661. DOI: https://doi.org/10.3389/fphar.2022.965661

INOUYE, S. K. et al. Delirium in older persons. New England Journal of Medicine, v. 384, n. 13, p. 1169–1177, 2021. DOI: https://doi.org/10.1056/NEJMra2107033.

KOTFIS, K.; ELY, E. W. Delirium: an update on diagnosis, prevention, and management. Current Opinion in Critical Care, v. 28, n. 2, p. 167–175, 2022. DOI: https://doi.org/10.1097/MCC.0000000000000934.

KOTFIS, K.; ELY, E. W. Delirium: an update on diagnosis, prevention, and management. Current Opinion in Critical Care, v. 28, n. 2, p. 167–175, 2022. DOI: https://doi.org/10.1097/MCC.0000000000000934. DOI: https://doi.org/10.1097/MCC.0000000000000934

LIAQUAT, Z. et al. The current role of dexmedetomidine as neuroprotective agent: an updated review. Brain Sciences, v. 11, n. 7, p. 846, 2021. DOI: https://doi.org/10.3390/brainsci11070846. DOI: https://doi.org/10.3390/brainsci11070846

MAIA, A. S. et al. Quadros de delírium em pacientes de terapia intensiva e a associação com sedoanalgesia: uma revisão bibliográfica. Brazilian Journal of Implantology and Health Sciences, v. 6, n. 1, p. 1479–1491, 2024. DOI: https://doi.org/10.47820/bjihs.v6i1.1293. DOI: https://doi.org/10.36557/2674-8169.2024v6n1p1479-1491

NEEDHAM, M. J. et al. Anaesthesia, surgery, and postoperative cognitive dysfunction and delirium: a narrative review. British Journal of Anaesthesia, v. 130, n. 3, p. 456–469, 2023. DOI: https://doi.org/10.1016/j.bja.2022.12.009. DOI: https://doi.org/10.1016/j.bja.2022.12.009

NG, K. T.; SHUBASH, C. J.; CHONG, J. S. The effect of dexmedetomidine on delirium and agitation in patients in intensive care: systematic review and meta-analysis with trial sequential analysis. Anaesthesia, v. 74, n. 3, p. 380–392, 2019. DOI: https://doi.org/10.1111/anae.14472. DOI: https://doi.org/10.1111/anae.14472

OH, E. S. et al. Preoperative risk factors for postoperative delirium following hip fracture repair: a systematic review. Journal of the American Geriatrics Society, v. 70, n. 2, p. 363–372, 2022. DOI: https://doi.org/10.1111/jgs.17576. DOI: https://doi.org/10.1111/jgs.17576

OUZZANI, M.; HAMMADY, H.; FEDOROWICZ, Z.; ELMAGARMID, A. Rayyan — a web and mobile app for systematic reviews. Systematic Reviews, v. 5, n. 1, p. 210, 2016. DOI: https://doi.org/10.1186/s13643-016-0384-4 DOI: https://doi.org/10.1186/s13643-016-0384-4

PENG, K. et al. Effect of perioperative dexmedetomidine on delirium after cardiac surgery: a meta-analysis with trial sequential analysis of randomized controlled trials. Frontiers in Medicine, v. 10, p. 1188472, 2023. DOI: https://doi.org/10.3389/fmed.2023.1188472.

SAHNI, N. et al. Postoperative delirium in elderly surgical patients: incidence, risk factors, and outcomes. Anesthesia & Analgesia, v. 134, n. 1, p. 76–86, 2022. DOI: https://doi.org/10.1213/ANE.0000000000005750. DOI: https://doi.org/10.1213/ANE.0000000000005750

SATTAR, L. et al. Comparison between dexmedetomidine and propofol for sedation on outcomes after cardiac surgery in patients requiring mechanical ventilation: a meta-analysis of randomized-controlled trials. Cureus, v. 15, n. 7, e42212, 2023. DOI: https://doi.org/10.7759/cureus.42212. DOI: https://doi.org/10.7759/cureus.42212

SU, X. et al. Dexmedetomidine for prevention of postoperative delirium in elderly patients undergoing non-cardiac surgery: a randomized, double-blind, placebo-controlled trial. The Lancet, v. 395, n. 10225, p. 1893–1902, 2020. DOI: https://doi.org/10.1016/S0140-6736(20)30766-6. DOI: https://doi.org/10.1016/S0140-6736(16)30580-3

TANG, S. et al. The effect of dexmedetomidine on emergence delirium of postanesthesia events in pediatric department: a systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore), v. 103, n. 36, e39337, 2024. DOI: https://doi.org/10.1097/MD.0000000000039337. DOI: https://doi.org/10.1097/MD.0000000000039337

URBANĚK, L. et al. Postoperative delirium. Rozhledy v chirurgii, v. 102, n. 10, p. 381–386, 2023. DOI: https://doi.org/10.33699/PIS.2023.102.10.381-386. DOI: https://doi.org/10.33699/PIS.2023.102.10.381-386

WANG, Y. et al. Dexmedetomidine effect on delirium in elderly patients undergoing general anesthesia: a protocol for systematic review and meta-analysis. Medicine, v. 100, n. 48, e27782, 2021. DOI: https://doi.org/10.1097/MD.0000000000027782. DOI: https://doi.org/10.1097/MD.0000000000027782

WANG, Y. et al. Esketamina intranasal mais dexmedetomidina versus dexmedetomidina sozinha para delírio de emergência em pacientes pediátricos: uma revisão sistemática e meta-análise de ensaios clínicos randomizados. BMC Anesthesiology, v. 26, p. 114, 2026. DOI: https://doi.org/10.1186/s12871-026-03628-y. DOI: https://doi.org/10.1186/s12871-026-03628-y

WU, H. et al. Effect of different intranasal dexmedetomidine doses on pediatric postoperative delirium and agitation: network meta-analysis. Pediatric Research, v. 98, n. 4, p. 1266–1275, 2025. DOI: https://doi.org/10.1038/s41390-025-03851-2. DOI: https://doi.org/10.1038/s41390-025-03851-2

YAHYA, C. Q. et al. Emergence agitation in pediatrics after dexmedetomidine vs. sevoflurane anesthesia: a randomized controlled trial. PLOS One, v. 20, n. 10, e0333576, 2025. DOI: https://doi.org/10.1371/journal.pone.0333576. DOI: https://doi.org/10.1371/journal.pone.0333576

YI, W. et al. The effect of two different doses of dexmedetomidine to prevent emergence agitation in children undergoing adenotonsillectomy: a randomized controlled trial. Brazilian Journal of Anesthesiology, v. 72, n. 1, p. 63–68, 2022. DOI: https://doi.org/10.1016/j.bjane.2021.08.019. DOI: https://doi.org/10.1016/j.bjane.2021.08.019

ZHAO, Y. et al. Study on the sedative effect of dexmedetomidine in radical prostatectomy: a retrospective study. Medicine, v. 104, n. 32, e43427, 2025. DOI: https://doi.org/10.1097/MD.0000000000043427 DOI: https://doi.org/10.1097/MD.0000000000043427

Published

2026-05-11

How to Cite

THE USE OF DEXMEDETOMIDINE IN REDUCING THE SYMPTOMS OF DELIRIUM AND PSYCHOMOTOR AGITATION POST-ANESTHESIA. (2026). REMUNOM, 13(09), 1-22. https://doi.org/10.66104/vrr9wh31